Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Squamous Cell Carcinoma of Head and Neck
Clinical trial register · France

Squamous Cell Carcinoma of Head and Neck Trials in France, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9730 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:21 UTC
9730
Studies in scope
all four open statuses
6053
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Villejuif 7 Lille 5 Marseille 4 Avignon 4 Paris 4

Squamous Cell Carcinoma of Head and Neck trials in France

11 of 9730 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 1
45
Brest, La Tronche, Lille, Marseille, Rouen, Villejuif
2026-01-26
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Avignon, Le Mans, Lille, Marseille, Paris, Rouen, Saint-Herblain, Villejuif
2025-12-03
Recruiting
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
NCT07151040Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck, Non-Small Cell Lung Cancer (NSCLC)
One-carbon Therapeutics AB
Phase 1/2
43
Villejuif
2025-08-22
Active, closed
Institut Claudius Regaud
Phase 2
86
Amiens, Avignon, Bordeaux, Clermont-Ferrand, Limoges, Marseille, Nantes, Nice
2024-10-21
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Avignon, Lille, Nantes, Paris, Villejuif
2024-04-22
Recruiting
IO Biotech
Phase 2
60
Lille, Paris
2023-12-21
Recruiting
UNICANCER
Phase 3
102
Avignon, Besançon, Bordeaux, Caen, Carcassonne, Clermont-Ferrand, Dijon, Le Havre
2021-12-01
Recruiting
Optimised Early Management of Squamous Cell Carcinoma of the Head and Neck Cancer
NCT04528420Squamous Cell Carcinoma of Head and Neck
Centre Henri Becquerel
Not applicable
138
Amiens, Beauvais, Caen, Le Havre, Lille, Rouen, Saint-Quentin
2020-11-26
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
1,006
Angers, Nice, Poitiers, Vandœuvre-lès-Nancy, Villejuif
2020-06-08
Active, closed
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
NCT04183166Squamous Cell Carcinoma of Head and Neck
Transgene
Phase 1/2
80
Bordeaux, Marseille, Paris, Toulouse, Villejuif
2019-12-12
Active, closed
Groupe Oncologie Radiotherapie Tete et Cou
Phase 3
680
Villejuif
2018-10-10
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-france/condition/squamous-cell-carcinoma-of-head-and-neck

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,730 studies in total at the last sync on 20 Nov 2026, 03:21 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Squamous Cell Carcinoma of Head and Neck.

How many Squamous Cell Carcinoma of Head and Neck trials are recruiting in France?

8 of the 11 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:21 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Squamous Cell Carcinoma of Head and Neck), 11 studies
PhaseStudiesRecruitingShare
Phase 1/23227.3%
Phase 33227.3%
Phase 12218.2%
Phase 22118.2%
Not applicable119.1%

Most active sponsors

Lead sponsors with the most studies (Squamous Cell Carcinoma of Head and Neck)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC22
Centre Henri Becquerel11
Groupe Oncologie Radiotherapie Tete et Cou10
Institut Claudius Regaud10
IO Biotech11
Johnson & Johnson Enterprise Innovation Inc.11
One-carbon Therapeutics AB11
Seagen, a wholly owned subsidiary of Pfizer11
Transgene10
UNICANCER11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.